{
  "id": "5ee7cec0-bbe5-4846-b4a0-ecd1c1a987a5",
  "title": "Popular equity categories lag in FY25; pharma schemes returned much more than the rest",
  "link": "https://economictimes.indiatimes.com/mf/analysis/popular-equity-categories-lag-in-fy25-pharma-schemes-returnedmuch-more-than-the-rest/articleshow/119834839.cms",
  "description": "​​The value of pharma schemes rose as investors shifted focus to drugmakers, considered defensive in uncertain times. As per data from Value Research the mid-cap category offered the highest return of 8.93%, followed by multi-caps which returned 7.88%.",
  "author": "",
  "published": "Tue, 01 Apr 2025 06:12:46 +0530",
  "source": "https://economictimes.indiatimes.com/rssfeedsdefault.cms",
  "categories": null,
  "byline": "Prashant Mahesh",
  "length": 1099,
  "excerpt": "​​The value of pharma schemes rose as investors shifted focus to drugmakers, considered defensive in uncertain times. As per data from Value Research the mid-cap category offered the highest return of 8.93%, followed by multi-caps which returned 7.88%.",
  "siteName": "Economic Times",
  "favicon": "",
  "text": "Pharma sector funds emerged as the top performing category among mutual funds in the financial year ended March 31, 2025, outperforming plain vanilla equity schemes. The risk-off sentiment in the second half of the financial year eroded a chunk of the returns in the most popular equity categories such as large-caps, midcap and small-cap schemes.The value of pharma schemes rose as investors shifted focus to drugmakers, considered defensive in uncertain times. As per data from Value Research the mid-cap category offered the highest return of 8.93%, followed by multi-caps which returned 7.88%. Small-caps and flexi-caps lagged, returning about 6.61% and 6.62%, respectively. The large-cap category returned the lowest of 5.47%, while the broad Nifty 50 benchmark returned 6.55%. AgenciesMulti-asset allocation outperformed several equity-fund categories because of their exposure to gold, which beat most asset classes. Amongst the hybrid funds, multi-asset funds that mix equity, debt and gold returned 9.4% followed by balanced and aggressive hybrid categories that returned 8.81% and 8.22%.",
  "image": "https://img.etimg.com/thumb/msid-119834818,width-1200,height-630,imgsize-665726,overlay-etwealthmutualfunds/articleshow.jpg",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-brcount=\"11\"\u003e\u003cp\u003e\u003ca ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#MF#href\" href=\"https://economictimes.indiatimes.com/topic/pharma-sector-funds\" target=\"_blank\"\u003ePharma sector funds\u003c/a\u003e emerged as the top performing category among mutual funds in the financial year ended March 31, 2025, outperforming plain vanilla equity schemes. The risk-off sentiment in the second half of the financial year eroded a chunk of the returns in the most popular equity categories such as large-caps, midcap and small-cap schemes.\u003c/p\u003e\u003cp\u003eThe value of pharma schemes rose as investors shifted focus to drugmakers, considered defensive in uncertain times. As per data from Value Research the mid-cap category offered the highest return of 8.93%, followed by multi-caps which returned 7.88%. \u003c/p\u003e\u003cp\u003eSmall-caps and flexi-caps lagged, returning about 6.61% and 6.62%, respectively. The large-cap category returned the lowest of 5.47%, while the broad Nifty 50 benchmark returned 6.55%. \u003c/p\u003e  \u003cdiv data-align=\"\" data-msid=\"119834850\" data-type=\"image\"\u003e\u003cfigure\u003e\u003cimg title=\"pharma\" alt=\"pharma\" src=\"https://img.etimg.com/photo/msid-119834850/pharma.jpg\" data-msid=\"119834850\" data-original=\"https://img.etimg.com/photo/msid-119834850/pharma.jpg\"/\u003e\u003cspan\u003eAgencies\u003c/span\u003e\u003c/figure\u003e\u003c/div\u003e\u003cp\u003eMulti-asset allocation outperformed several equity-fund categories because of their exposure to gold, which beat most asset classes. \u003c/p\u003e\u003cp\u003eAmongst the hybrid funds, multi-asset funds that mix equity, debt and gold returned 9.4% followed by balanced and aggressive hybrid categories that returned 8.81% and 8.22%.\u003c/p\u003e\u003cbr/\u003e\u003cbr/\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "2 min read",
  "publishedTime": "2025-04-01T06:12:00+05:30",
  "modifiedTime": null
}
